💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Isis Pharmaceuticals, Inc. (ISIS)
« Back to company indexISIS Chatter Timeline
Stock Ticker for ISIS
Most Active Tweeters for ISIS
| User | Tweets |
|---|---|
| @FlashAlert_me | 8 |
| @Allstocknews | 7 |
| @_ViralTaco | 1 |
Recent Tweets for ISIS
 |
@Allstocknews $ISIS New Form 4 for Ionis Pharmaceuticals Inc From our Stock News Alerts App March 3rd 2021, 1:03am |
 |
@FlashAlert_me $ISIS [15s. delayed] filed SEC form 4: EVP, Research Swayze Eric: Acquired 460 of Common Stock at price $44.54 on… https://t.co/5bUEbYBHWA March 3rd 2021, 1:03am |
|
@FlashAlert_me $ISIS [15s. delayed] filed SEC form 4: EVP & General Counsel O'NEIL PATRICK R.: Acquired 197 of Common Stock at pr… https://t.co/dsstvXrpoS March 3rd 2021, 1:03am |
|
@FlashAlert_me $ISIS [15s. delayed] filed SEC form 4: EVP, Finance & CFO HOUGEN ELIZABETH L: Acquired 116 of Common Stock at pric… https://t.co/1ghGrS7H4c March 3rd 2021, 1:03am |
|
@FlashAlert_me $ISIS [15s. delayed] filed SEC form 4: EVP, Chief Development Offc Geary Richard S: Acquired 414 of Common Stock a… https://t.co/YVUBwdj1dS March 3rd 2021, 1:03am |
|
@FlashAlert_me $ISIS [15s. delayed] filed SEC form 4: Chief Corp Dev and Cml Officer Cadoret-Manier Onaiza: Acquired 492 of Commo… https://t.co/Z3svTfXl6v March 3rd 2021, 1:03am |
|
@FlashAlert_me $ISIS [15s. delayed] filed SEC form 4: Chief Scientific Officer BENNETT C FRANK: Acquired 112 of Common Stock at p… https://t.co/s6IlvEvNce March 3rd 2021, 1:03am |
|
@FlashAlert_me $ISIS [15s. delayed] filed SEC form 4: Chief Executive Officer Monia Brett P: Disposed 236 of Common Stock at pric… https://t.co/98oVbWq2lu March 3rd 2021, 1:03am |
 |
@_ViralTaco @russian_market $ISIS March 2nd 2021, 11:03am |
|
@Allstocknews $ISIS Ionis establishes new grant program to advance research and understanding of transthyretin amyloidosis From our Stock News Alerts App March 1st 2021, 12:03pm |
|
@Allstocknews $ISIS Ionis Pharmaceuticals Inc - SVB Leerink 10th Annual Global Healthcare Conference From our Stock News Alerts App February 25th 2021, 12:02pm |
|
@Allstocknews $ISIS New Form 10-K for Ionis Pharmaceuticals Inc From our Stock News Alerts App February 24th 2021, 9:02pm |
|
@FlashAlert_me $ISIS [15s. delayed] filed form 10-K on February 24, 15:34:10 https://t.co/k89NTJylNL February 24th 2021, 8:02pm |
|
@Allstocknews $ISIS New Form 8-K for Ionis Pharmaceuticals Inc From our Stock News Alerts App February 24th 2021, 2:02pm |
|
@Allstocknews $ISIS Ionis reports fourth quarter and full year 2020 financial results and recent business achievements From our Stock News Alerts App February 24th 2021, 12:02pm |
|
@Allstocknews $ISIS Ionis Pharmaceuticals Inc - Fourth Quarter 2020 Earnings Webcast From our Stock News Alerts App February 23rd 2021, 12:02pm |
|
@Allstocknews $ISIS Ionis to present at upcoming investor conferences From our Stock News Alerts App February 19th 2021, 12:02pm |
|
@Allstocknews $ISIS New Form SC 13G for Ionis Pharmaceuticals Inc From our Stock News Alerts App February 16th 2021, 5:02pm |
 |
@violent_words just invested $5k in $ISIS i think they're really gonna blow up this year February 16th 2021, 4:02am |
 |
@spacemangp RT @saucegod3000: @appledoglives $ISIS to the moon !!!!!!! ???? February 16th 2021, 4:02am |
 |
@saucegod3000 @appledoglives $ISIS to the moon !!!!!!! ???? February 16th 2021, 4:02am |
 |
@KRespekter @appledoglives buy $ISIS February 16th 2021, 3:02am |
|
@Allstocknews $ISIS Ionis to hold 2020 financial results webcast From our Stock News Alerts App February 11th 2021, 12:02pm |
 |
@Fleance_II Heard $ISIS is surging back!!! ??? February 7th 2021, 10:02pm |
|
@Allstocknews $ISIS New Form SC 13G/A for Ionis Pharmaceuticals Inc From our Stock News Alerts App February 5th 2021, 12:02pm |
 |
@nihilum_000 buy $ISIS b4 tha next jihad February 2nd 2021, 5:02am |
|
@FlashAlert_me $ISIS [15s. delayed] filed SEC form 4: Exec Chairman of the Board CROOKE STANLEY T: Disposed 75,000 of Common Stoc… https://t.co/t68ZXiVPbN January 26th 2021, 1:01am |
 |
@kamal_abo_taleb The ongoing war on #Yemen has proven that the #US is fighting on the same side with $ISIS & #Al_Qaeda, even though… https://t.co/SNjIEJOWUZ January 25th 2021, 6:01pm |
|
@FlashAlert_me $ISIS [15s. delayed] filed SEC form 4: Chief Corp Dev and Cml Officer Cadoret-Manier Onaiza: Transacted Derivative… https://t.co/4bnFBEPjXc January 21st 2021, 12:01am |
|
@FlashAlert_me $ISIS [15s. delayed] filed SEC form 4: EVP, Finance & CFO HOUGEN ELIZABETH L: Delivered securities 6,175 of Common… https://t.co/dcYIJjzXer January 21st 2021, 12:01am |
|
@FlashAlert_me $ISIS [15s. delayed] filed SEC form 4: Chief Executive Officer Monia Brett P: Delivered securities 14,927 of Commo… https://t.co/AkwteL7FOA January 21st 2021, 12:01am |
|
@FlashAlert_me $ISIS [15s. delayed] filed SEC form 4: Director PARSHALL B LYNNE: Delivered securities 2,741 of Common Stock at pr… https://t.co/lXaEQg9L5y January 21st 2021, 12:01am |
|
@FlashAlert_me $ISIS [15s. delayed] filed SEC form 4: EVP, Research Swayze Eric: Delivered securities 3,216 of Common Stock at pr… https://t.co/mxECPaaZSB January 20th 2021, 11:01pm |
 |
@AraujoOLuisF RT @baran_MR_: After growing heat of $ISIS and #Syria war, the Syrian govern man ask help from United States, but they delay it to six mont… January 17th 2021, 6:01pm |
|
@FlashAlert_me $ISIS [15s. delayed] filed SEC form 4: EVP, Chief Development Offc Geary Richard S: Disposed 141 of Common Stock a… https://t.co/2uhTjSGMJn January 15th 2021, 10:01pm |
 |
@baran_MR_ After growing heat of $ISIS and #Syria war, the Syrian govern man ask help from United States, but they delay it to… https://t.co/IHmwltu3Z4 January 12th 2021, 7:01pm |
 |
@SuperHovo @jessica_esquire $ISIS January 12th 2021, 1:01am |
|
@Allstocknews $ISIS Ionis Pharmaceuticals Inc - 39th Annual J.P. Morgan Healthcare Conference From our Stock News Alerts App January 11th 2021, 12:01pm |
|
@Allstocknews $ISIS Ionis appoints Eugene Schneider, M.D., as executive vice president and chief clinical development offic From our Stock News Alerts App January 7th 2021, 6:01pm |
|
@Allstocknews $ISIS New Form 3 for Ionis Pharmaceuticals Inc From our Stock News Alerts App January 6th 2021, 9:01pm |
|
@FlashAlert_me $ISIS [15s. delayed] filed SEC form 4: EVP, Chf Clinical Develop Offc Schneider Eugene: Transacted Derivative Secu… https://t.co/JlpavtUnbp January 6th 2021, 9:01pm |
|
@FlashAlert_me $ISIS [15s. delayed] filed SEC form 3: EVP, Chf Clinical Develop Offc Schneider Eugene: https://t.co/JbeRAp3es8 January 6th 2021, 9:01pm |
|
@Allstocknews $ISIS New Form 5 for Ionis Pharmaceuticals Inc From our Stock News Alerts App January 6th 2021, 9:01pm |
|
@FlashAlert_me $ISIS [15s. delayed] filed SEC form 4: EVP, Research Swayze Eric: Disposed 195 of Common Stock at price $55.99 on… https://t.co/l5moOhOi9R January 6th 2021, 9:01pm |
|
@FlashAlert_me $ISIS [15s. delayed] filed SEC form 4: Exec Chairman of the Board CROOKE STANLEY T: Transacted Derivative Securiti… https://t.co/kno2SPMPxz January 6th 2021, 9:01pm |
|
@FlashAlert_me $ISIS [15s. delayed] filed SEC form 5: Executive Chairman of Board CROOKE STANLEY T: Gifted 31,000 of Common Stock… https://t.co/deMNiU4zNY January 6th 2021, 9:01pm |
|
@FlashAlert_me $ISIS [15s. delayed] filed SEC form 4: EVP & General Counsel O'NEIL PATRICK R.: Transacted Derivative Securities o… https://t.co/G2b9zvbSNo January 6th 2021, 9:01pm |
|
@FlashAlert_me $ISIS [15s. delayed] filed SEC form 4: Chief Executive Officer Monia Brett P: Transacted Derivative Securities on… https://t.co/qHW7RugOgu January 6th 2021, 9:01pm |
|
@FlashAlert_me $ISIS [15s. delayed] filed SEC form 4: EVP, Finance & CFO HOUGEN ELIZABETH L: Transacted Derivative Securities on… https://t.co/vv8pd8GT0E January 6th 2021, 9:01pm |
|
@FlashAlert_me $ISIS [15s. delayed] filed SEC form 4: EVP, Development Geary Richard S: Transacted Derivative Securities on 2021-… https://t.co/klcoquV6XS January 6th 2021, 9:01pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
Get the DrugPatentWatch Daily Briefing
Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …
Want insights into the biggest revenue-changing events?
Billions of dollars in sales can evaporate overnight as drug patents expire and competitors enter the market.
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
➤ Free Trial
